Lynwood Capital Management Inc. / VRTX
Lynwood Capital Management Inc.’s Vertex Pharmaceuticals Inc Position
Does Lynwood Capital Management Inc. own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 5.0K shares worth $1M in Q3 2022; the fund’s latest 13F (Q1 2024) no longer reports it.
Position Value
$1M
Q3 2022
Shares
5.0K
% of Portfolio
+1.58%
Quarters Held
1
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 5.0K | $1M | +1.58% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lynwood Capital Management Inc.’s full portfolio or all institutional holders of VRTX.